THB Asset Management’s Anika Therapeutics ANIK Stock Holding History

THB Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-205,609	Closed	-$6.22M	–	163
2019 Q1	$6.22M	Sell	205,609 -31,003	-13%	-$1.06M	0.9%	40
2018 Q4	$7.95M	Sell	236,612 -13,405	-5%	-$484K	1.18%	28
2018 Q3	$10.5M	Sell	250,017 -14,734	-6%	-$582K	1.29%	19
2018 Q2	$8.47M	Buy	264,751 +21,955	+9%	+$904K	1.03%	38
2018 Q1	$12.1M	Sell	242,796 -294	-0.1%	-$16.6K	1.58%	11
2017 Q4	$13.1M	Buy	243,090 +25,661	+12%	+$1.42M	1.73%	7
2017 Q3	$12.6M	Sell	217,429 -12,515	-5%	-$654K	1.73%	8
2017 Q2	$11.3M	Buy	+229,944	New	+$10.6M	1.47%	17
2015 Q2	–	Sell	-179,093	Closed	-$7.37M	–	213
2015 Q1	$7.37M	Buy	179,093 +133,743	+295%	+$5.41M	0.52%	71
2014 Q4	$1.85M	Buy	45,350 +350	+0.8%	+$13.7K	0.12%	196
2014 Q3	$1.65M	Buy	+45,000	New	+$1.94M	0.11%	193

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

THB Asset Management's ANIK Position: Q2 2019 in Review

THB Asset Management sold out of Anika Therapeutics (ANIK) in Q2 2019, closing a stake of 205,609 shares — an estimated $6.22M sold.

THB Asset Management first reported a position in ANIK in Q3 2014 and held it in 11 quarters. The position peaked at $13.1M in Q4 2017. 165 funds tracked by Wall St. Rank hold ANIK as of Q2 2019.

THB Asset Management reported no remaining Anika Therapeutics position as of Q2 2019 after selling out during the quarter.
THB Asset Management sold 205,609 Anika Therapeutics shares in Q2 2019, an estimated $6.22M.
THB Asset Management first reported a position in Anika Therapeutics in Q3 2014 and held it in 11 quarters.
THB Asset Management's Anika Therapeutics position peaked at $13.1M in Q4 2017.
165 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2019.

Based on THB Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.